JIANGXI BANK
01916
ZYBANK
01216
CM BANK
03968
MINSHENG BANK
01988
PSBC
01658
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -99.37%145K | 130.57%31.19M | 120.90%22.91M | -178.72%-102.04M | -186.00%-109.62M | -48.39%129.63M | -1.09%127.47M | 8.02%251.17M | -1.98%128.88M | 90.33%232.53M |
Operating income | -99.37%145K | 130.57%31.19M | 120.90%22.91M | -178.72%-102.04M | -186.00%-109.62M | -48.39%129.63M | -1.09%127.47M | 8.02%251.17M | -1.98%128.88M | 90.33%232.53M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Employee expense | 17.71%-11.53M | 39.78%-25.63M | 41.00%-14.01M | 15.30%-42.55M | 41.94%-23.74M | 48.23%-50.24M | -23.97%-40.89M | -29.04%-97.04M | 16.07%-32.98M | 21.96%-75.2M |
Depreciation and amortization | 49.03%-263K | 95.13%-804K | 93.77%-516K | 7.64%-16.52M | 8.92%-8.28M | 5.05%-17.89M | 4.60%-9.1M | 20.19%-18.84M | 28.20%-9.53M | -116.06%-23.61M |
Revaluation surplus | ---- | ---- | ---- | 226.07%440K | 986.96%408K | ---349K | ---46K | ---- | ---- | ---- |
-Changes in the fair value of other assets | ---- | ---- | ---- | 226.07%440K | 986.96%408K | ---349K | ---46K | ---- | ---- | ---- |
Impairment and provision | -100.50%-9K | ---- | 200.89%1.82M | ---- | -480.17%-1.8M | 98.99%-1.5M | 100.35%474K | 53.13%-149.29M | -149.23%-133.88M | -4,091.84%-318.54M |
-Other impairment is provision | -100.50%-9K | ---- | 200.89%1.82M | ---- | -480.17%-1.8M | 98.99%-1.5M | 100.35%474K | 53.13%-149.29M | -149.23%-133.88M | -4,091.84%-318.54M |
Special items of operating profit | 136.51%1.91M | 148.10%11.05M | 103.85%808K | 30.15%-22.98M | -20.71%-20.97M | -290.92%-32.9M | 19.85%-17.38M | 63.71%-8.42M | -210.66%-21.68M | 80.76%-23.19M |
Operating profit | -188.45%-9.74M | 108.61%15.81M | 106.72%11.02M | -786.36%-183.66M | -370.92%-164.02M | 219.43%26.76M | 187.48%60.54M | 89.23%-22.41M | -480.08%-69.2M | -481.14%-208M |
Financing cost | 61.97%-6.3M | 44.85%-31.76M | 55.92%-16.58M | 32.85%-57.58M | 31.98%-37.6M | 26.14%-85.74M | 4.70%-55.28M | 16.39%-116.08M | 26.07%-58.01M | 5.22%-138.84M |
Earning before tax | -188.56%-16.05M | 93.39%-15.94M | 97.24%-5.56M | -308.99%-241.23M | -3,933.06%-201.62M | 57.41%-58.98M | 104.13%5.26M | 60.07%-138.49M | -111.13%-127.21M | -76.29%-346.84M |
Tax | ---- | ---- | ---- | --96K | ---- | ---- | ---- | ---- | ---- | 144.86%2.24M |
After-tax profit from continuing operations | -188.56%-16.05M | 93.39%-15.94M | 97.24%-5.56M | -308.83%-241.14M | -3,933.06%-201.62M | 57.41%-58.98M | 104.13%5.26M | 59.81%-138.49M | -111.40%-127.21M | -70.80%-344.6M |
Earning after tax | -188.56%-16.05M | 93.39%-15.94M | 97.24%-5.56M | -308.83%-241.14M | -3,933.06%-201.62M | 57.41%-58.98M | 104.13%5.26M | 59.81%-138.49M | -111.40%-127.21M | -70.80%-344.6M |
Minority profit | ---- | ---- | ---- | ---- | ---- | --4.8M | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -188.56%-16.05M | 93.39%-15.94M | 97.24%-5.56M | -278.04%-241.14M | -3,933.06%-201.62M | 53.94%-63.79M | 104.13%5.26M | 59.81%-138.49M | -111.40%-127.21M | -70.80%-344.6M |
Basic earnings per share | -193.33%-0.0044 | 93.32%-0.0044 | 97.28%-0.0015 | -278.74%-0.0659 | -4,035.71%-0.0551 | 53.97%-0.0174 | 104.03%0.0014 | 62.31%-0.0378 | -85.56%-0.0347 | -29.09%-0.1003 |
Diluted earnings per share | -193.33%-0.0044 | 93.32%-0.0044 | 97.28%-0.0015 | -278.74%-0.0659 | -4,035.71%-0.0551 | 53.97%-0.0174 | 104.03%0.0014 | 62.31%-0.0378 | -85.56%-0.0347 | -29.09%-0.1003 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.